Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Galera Therapeutics Inc
(NQ:
GRTX
)
3.160
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
367,798
Open
3.200
Bid (Size)
3.160 (3)
Ask (Size)
3.270 (59)
Prev. Close
3.160
Today's Range
3.130 - 3.289
52wk Range
1.120 - 3.500
Shares Outstanding
42,906,833
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
May 18, 2023
Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapy
From
Galera Therapeutics
Via
GlobeNewswire
Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates
May 11, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Performance
YTD
+113.51%
+113.51%
1 Month
+0.32%
+0.32%
3 Month
+69.89%
+69.89%
6 Month
+88.10%
+88.10%
1 Year
+97.50%
+97.50%
More News
Read More
Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 04, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Analyst Ratings for Galera Therapeutics
March 22, 2023
Via
Benzinga
Where Galera Therapeutics Stands With Analysts
March 22, 2023
Via
Benzinga
Galera Expands Commercial Leadership Team
May 01, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Galera to Present One-Year Reductions in Cisplatin-Related Chronic Kidney Disease Data from ROMAN Trial at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
April 26, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology
March 10, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
March 08, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 15, 2023
Via
Benzinga
Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants
February 15, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis
February 15, 2023
From
Galera Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 16, 2023
Via
Benzinga
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
December 12, 2022
From
Galera Therapeutics
Via
GlobeNewswire
Galera to Present at Piper Sandler Annual Healthcare Conference
November 22, 2022
From
Galera Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 17, 2022
Via
Benzinga
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
November 09, 2022
From
Galera Therapeutics
Via
GlobeNewswire
Galera Therapeutics' Avasopasem Reduces Chemo-Related Kidney Disease By 50% Versus Placebo At One-Year
October 26, 2022
Via
Benzinga
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
October 26, 2022
From
Galera Therapeutics
Via
GlobeNewswire
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
September 26, 2022
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 02, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.